查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018753

開放式磁振造影系統市場：按組件、磁場強度、成像模式、應用和最終用戶分類－2026年至2032年全球市場預測

Open MRI Systems Market by Component, Field Strength, Imaging Mode, Application, End Users - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，開放式 MRI 系統市值將達到 17.7 億美元，到 2026 年將成長到 19.1 億美元，到 2032 年將達到 31.2 億美元，複合年成長率為 8.45%。

主要市場統計數據
基準年 2025 17.7億美元
預計年份：2026年 19.1億美元
預測年份 2032 31.2億美元
複合年成長率 (%) 8.45%

對開放式 MRI 系統進行全面介紹，重點在於臨床益處、以患者為中心、技術成熟度和操作注意事項。

開放式磁振造影(MRI) 系統代表著影像架構的重大變革，旨在提升病患舒適度、臨床可及性和操作柔軟性。與傳統的封閉式磁振造影平台不同，開放式 MRI 解決方案優先考慮患者體驗，透過減少恐懼症，並方便行動不便或體內植入醫療器材的患者進行檢查。這些設計理念對臨床工作流程、麻醉需求和放射科實驗室容量有著顯著的影響，尤其是在門診、兒童和肌肉骨骼疾病診療領域。

分析了近期透過硬體進步、基於軟體的影像重建、分散式醫療服務以及不斷變化的患者期​​望等變革性變化，這些變化正在重塑開放式 MRI 系統。

開放式磁振造影系統正經歷一場變革，其驅動力來自於技術進步、醫療服務模式的轉變以及患者期望的不斷提高。首先，梯度線圈工程和射頻（RF）系統設計的改進顯著提升了非常規磁鐵配置的空間解析度和訊號雜訊比。這些硬體進步與影像重建、偽影抑制和自動化後處理方面的軟體改進相輔相成，共同拓展了開放式平台的臨床效用。

詳細檢驗了美國累積關稅措施在 2025 年如何重塑診斷影像系統的籌資策略、採購風險管理和成本彈性。

美國政策和貿易趨勢為診斷成像平台的採購經濟性和供應鏈策略帶來了許多影響。到2025年，關稅累積調整和進口限制的變化已經影響到進口零件和成品系統的成本結構，尤其是那些通常從全球供應商採購的子組件和磁性組件。隨著關稅措施的持續，許多相關人員正在透過重新評估供應商選擇、增加庫存緩衝以及探索替代貨源來應對，以確保供應的連續性並控制價格波動風險。

將組件架構、磁場強度選擇、成像模式、臨床應用和最終用戶優先順序與實施和採購決策聯繫起來的詳細細分見解。

精細化的細分為臨床和商業相關人員提供了觀點，其中組件層面、磁場強度、成像模式、應用和最終用戶等方面的差異都會影響採購和部署決策。基於組件層面的考慮，相關人員認知到線圈幾何形狀和射頻鏈路設計的進步對影像保真度和協議柔軟性有著顯著影響，並評估梯度線圈、磁體、電源單元和射頻系統的相對優勢。這些組件層面的差異也會影響維修程序、備件策略以及生物醫學團隊的訓練需求等方面的決策。

區域性洞察揭示了主要區域部署因素、法規環境和基礎設施的差異如何影響開放式 MRI 部署策略。

區域趨勢對美洲、歐洲、中東和非洲以及亞太地區開放式磁振造影技術的應用模式、監管考量和供應鏈策略有著至關重要的影響。在美洲，需求主要由大規模公立和私人醫療系統驅動，這些系統優先考慮患者體驗、擴大門診服務範圍以及製定有利於臨床應用的監管路徑。該地區的資本規劃往往需要在成本意識和以患者為中心的設施需求之間取得平衡，尤其是在競爭激烈的都市區市場，差異化能夠顯著影響轉診趨勢。

對競爭因素進行策略性審查，展示產品工程、組件專業化、生命週期服務和夥伴關係關係如何定義開放式 MRI 系統的領導地位。

開放式磁振造影系統領域的競爭動態是由成熟的成像設備製造商、專業組件供應商和靈活的整合商共同塑造的，這些整合商彌合了硬體和軟體能力之間的差距。將磁鐵和梯度線圈的穩健工程設計與先進的射頻管理和重建演算法相結合的製造商往往能贏得臨床的廣泛信賴。同時，提供創新梯度線圈、高效能電源單元和新一代射頻鏈路的供應商在實現平台差異化方面發揮著至關重要的作用。

為產品模組化、整合軟體開發、彈性供應鏈、增強型服務模式和以結果為導向的商業策略提供實用建議。

產業領導企業應優先考慮一系列切實可行的措施，使產品開發、商業策略和業務永續營運與不斷變化的臨床和法規環境保持一致。首先，投資於模組化平台架構，實現梯度組件、射頻子系統和功率電子設備的逐步升級，從而延長使用壽命並減少整系統更換的需求。這種方法使醫療機構能夠在保持技術先進性的同時，規分類階段的資本投資。

我們高度透明的調查方法，結合了相關人員訪談、技術基準測試、第二手資料分析和基於情境的敏感度分析，得出了可靠的見解。

本分析所依據的研究結合了定性和定量方法，旨在全面且可重複地了解目前開放式磁振造影系統的現狀。主要資訊來源包括對具有代表性的醫療服務機構中的臨床負責人、生物醫學工程師、採購負責人和服務經理進行的結構化訪談。除訪談外，分析還包括對組件架構的技術評估、公開的監管文件以及側重於成像性能和患者預後的同行評審臨床文獻。

簡明結論總結了開放式 MRI 平台的策略意義、技術進步、供應鏈挑戰和實際實施考量。

開放式磁振造影系統在現代影像生態系統中扮演著日益重要且複雜多變的角色，它提供以患者為中心的多種選擇，與不斷發展的醫療服務模式相契合。梯度和射頻設計方面的技術進步，以及重建軟體的改進，縮小了效能差距，並擴大了臨床應用範圍。同時，供應鏈和政策壓力凸顯了製定穩健的籌資策略和高度靈活的服務提案的必要性，這些策略和方案應優先考慮長期營運的連續性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：開放式磁振造影系統市場：依組件分類

  • 梯度線圈
  • 磁鐵
  • 電源單元
  • 高頻系統

第9章：開放式磁振造影系統市場：依磁場強度分類

  • 高磁場強度
  • 低磁場強度
  • 中等磁場強度

第10章 開放式磁振造影系統市場：依影像模式分類

  • 2D成像
  • 3D成像

第11章 開放式磁振造影系統市場：依應用領域分類

  • 乳房攝影
  • 心血管影像
  • 神經影像學
  • 脊椎和肌肉骨骼影像診斷

第12章 開放式磁振造影系統市場：依最終用戶分類

  • 門診手術中心
  • 診斷中心
  • 醫院
  • 研究機構

第13章 開放式磁振造影系統市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 開放式磁振造影系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 開放式磁振造影系統市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國開放式磁振造影系統市場

第17章：中國開放式磁振造影系統市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Alliance Medical Systems
  • ASG Superconductors spa
  • Barco NV
  • Beijing Wandong Medical Technology Co.
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Esaote SpA
  • Fonar Corporation
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Hitachi Healthcare Manufacturing, Ltd.
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Paramed Medical Systems, Inc.
  • Siemens AG
  • SternMed GmbH
  • VISION STAR PRIVATE LIMITED
Product Code: MRR-A26E0E57415E

The Open MRI Systems Market was valued at USD 1.77 billion in 2025 and is projected to grow to USD 1.91 billion in 2026, with a CAGR of 8.45%, reaching USD 3.12 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.77 billion
Estimated Year [2026] USD 1.91 billion
Forecast Year [2032] USD 3.12 billion
CAGR (%) 8.45%

A comprehensive introduction to open MRI systems highlighting clinical advantages, patient centricity, technological maturation, and operational considerations

Open magnetic resonance imaging (MRI) systems represent a purposeful shift in diagnostic imaging architecture designed to address patient comfort, clinical accessibility, and operational flexibility. Unlike conventional closed-bore platforms, open MRI solutions prioritize patient experience by reducing claustrophobia and enabling easier access for patients with mobility constraints or implanted devices. These design priorities translate into meaningful differences in clinical workflow, anesthetic needs, and the throughput profile of imaging suites, particularly in settings that emphasize outpatient, pediatric, and musculoskeletal care.

Technological maturity in coil design, magnet engineering, and radio frequency management has narrowed historical gaps in image fidelity between open and closed systems. As a result, clinicians can increasingly rely on open MRI for a broader range of diagnostic applications while benefitting from improved ergonomics. At the same time, service providers and health system planners evaluate open MRI on multiple operational axes: scan time efficiency, staff training requirements, integration with PACS and hospital information systems, and lifecycle serviceability. Therefore, decisions around adoption extend beyond clinical performance to encompass total cost of ownership drivers, site-specific throughput goals, and patient satisfaction metrics.

In this context, stakeholders must balance clinical requirements with capital planning, site constraints, and patient demographics. The introduction of novel component architectures and software-enabled image reconstruction has accelerated the pace at which open platforms can meet expanding clinical indications. Consequently, strategic conversations among clinical leaders, procurement teams, and technology providers are increasingly focused on the role of open MRI as a complement to, rather than a replacement for, high-field closed systems.

An analysis of recent transformative shifts reshaping open MRI systems through hardware advances, software reconstruction, decentralized care delivery, and evolving patient expectations

The landscape for open MRI systems is experiencing transformative shifts driven by converging technological advancements, changing care delivery models, and evolving patient expectations. First, improvements in gradient coil engineering and radio frequency (RF) system design have meaningfully enhanced spatial resolution and signal-to-noise ratio in non-traditional magnet configurations. These hardware gains are complemented by software advances in image reconstruction, artifact suppression, and automated post-processing, which together expand the clinical utility of open platforms.

Second, healthcare delivery is shifting toward ambulatory and decentralized models that prioritize shorter visits and higher patient throughput. As outpatient diagnostic centers proliferate, open MRI platforms that emphasize patient comfort and simplified access are gaining strategic relevance. This shift is reinforced by workforce considerations: technicians and radiologists are seeking systems that reduce positioning time and simplify protocol standardization across diverse patient populations.

Third, patient expectations are changing in ways that directly influence modality selection. A growing emphasis on patient experience metrics and consumer-style expectations for care environments means that imaging providers must weigh patient satisfaction as a factor in modality procurement. Open MRI's capacity to accommodate claustrophobic, pediatric, and bariatric patients without sedation aligns with these expectations and may reduce ancillary resource utilization.

Fourth, supply chain dynamics and component modularity are reshaping procurement and service models. Manufacturers are increasingly emphasizing modular components-such as separable gradient assemblies and swappable RF chains-that enable rapid upgrades and localized servicing. These modular approaches support longer equipment lifecycles and allow providers to phase capability enhancements without full platform replacement. Taken together, these shifts are redefining the competitive landscape for product developers, service partners, and health systems as they weigh investment priorities against clinical and operational outcomes.

A focused examination of how cumulative United States tariff actions through 2025 have reshaped sourcing strategies, procurement risk management, and cost resilience for diagnostic imaging systems

Policy and trade developments in the United States have introduced a range of considerations that influence procurement economics and supply chain strategies for diagnostic imaging platforms. Tariff adjustments and import regulatory changes that accumulated through 2025 have affected cost structures for imported components and finished systems, particularly for subassemblies and magnet elements often sourced across global suppliers. As tariffs have persisted, many stakeholders have responded by reassessing supplier footprints, increasing inventory buffers, and exploring alternative sourcing to stabilize supply continuity and manage price exposure.

These developments have prompted manufacturers and system integrators to accelerate supply chain de-risking, including qualifying secondary suppliers outside traditional sourcing regions and investing in nearshoring of critical components. Consequently, capital allocation decisions for product development and manufacturing expansion increasingly account for potential trade policy volatility. For health systems and diagnostic centers, procurement strategies have adapted to include lifecycle maintenance agreements and local service partnerships that can mitigate disruption risks associated with cross-border parts movement.

At the clinical operations level, the cumulative effect of tariff-driven input cost pressures has manifested in extended evaluation timelines for capital acquisitions and more rigorous total cost assessments during vendor selection. Vendors that demonstrate resilient logistics, transparent cost pass-through practices, and onshore stocking capabilities have seen improved receptivity among procurement committees. In summary, trade policy dynamics through 2025 have catalyzed a strategic shift from purely price-focused procurement toward an integrated resilience and value-based purchasing mindset that accounts for operational continuity and long-term serviceability.

Detailed segmentation insights that connect component architecture, field strength choices, imaging modes, clinical applications, and end-user priorities to deployment and procurement decisions

Granular segmentation provides the lens through which clinical and commercial stakeholders evaluate open MRI platforms, with component-level, field strength, imaging mode, application, and end-user distinctions each driving distinct procurement and deployment decisions. Based on component considerations, stakeholders assess the comparative advantages of gradient coils, magnets, power supply units, and radio frequency systems, recognizing that advances in coil geometry and RF chain design materially influence image fidelity and protocol flexibility. These component-level distinctions also inform maintenance regimes, spares strategy, and training requirements for biomed teams.

Field strength segmentation further differentiates platform selection along clinical performance and patient-safety lines. High field strength systems prioritize resolution for complex neurological and cardiovascular imaging, while low field strength systems emphasize safety for implanted device patients and operational simplicity. Mid field strength solutions often aim to balance these imperatives, offering an intermediate path that supports broader clinical indications without the infrastructure demands of the highest-field platforms.

Imaging mode distinctions, including 2D and 3D imaging capabilities, shape the clinical workflows and post-processing needs of imaging centers. Two-dimensional protocols remain prevalent for routine screening and follow-up examinations due to their speed and reduced computational overhead, while three-dimensional imaging is increasingly leveraged for advanced diagnostic tasks and surgical planning, particularly as reconstruction algorithms reduce acquisition time penalties.

Application-driven segmentation clarifies which clinical domains most readily benefit from open configurations. Breast imaging, cardiovascular imaging, neurological imaging, and spine and musculoskeletal imaging each present unique requirements in terms of coil design, patient positioning, and protocol optimization. Devices tailored for musculoskeletal and breast imaging often capitalize on targeted coils and shorter exam times, whereas neurological and cardiovascular applications demand higher spatial resolution and more sophisticated motion-management techniques.

Finally, end-user segmentation - spanning ambulatory surgical centers, diagnostic centers, hospitals, and research organizations - determines procurement cadence, service expectations, and capital deployment models. Ambulatory and diagnostic centers typically prioritize throughput and patient experience, hospitals focus on clinical breadth and interoperability with enterprise systems, and research organizations emphasize configurability and extensible hardware and software interfaces. Understanding how these segmentation axes interact allows stakeholders to map technology capabilities to real-world clinical and operational needs with greater precision.

Region-specific insights revealing how adoption drivers, regulatory environments, and infrastructural differences across major geographies influence open MRI deployment strategies

Regional dynamics exert a defining influence on adoption patterns, regulatory considerations, and supply chain strategies for open MRI technologies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, demand is shaped by large private and public health systems that emphasize patient experience, outpatient expansion, and regulatory pathways that facilitate clinical deployment. Capital planning in this region tends to balance cost sensitivity with the need for patient-centric amenities, particularly in competitive urban markets where differentiation can drive referral patterns.

Europe, the Middle East & Africa present a heterogenous landscape where reimbursement regimes, regulatory harmonization efforts, and infrastructural variability drive differentiated adoption trajectories. Western European markets typically prioritize integration with hospital IT ecosystems and adherence to rigorous clinical guidelines, while parts of the Middle East & Africa may emphasize infrastructure resilience and serviceability given regional logistical constraints. In these contexts, vendors that offer adaptable service models and strong local partnerships tend to secure enduring relationships with health systems and private providers.

Asia-Pacific encompasses a diverse set of market dynamics, including rapid clinical capacity expansion in urban centers, targeted investments in diagnostic infrastructure, and varying regulatory environments. Governments and large healthcare groups in the region often pursue capacity-building initiatives that favor scalable, cost-effective imaging solutions suitable for both tertiary hospitals and emerging outpatient networks. Across all regions, the interplay of reimbursement structures, workforce availability, and patient demographics shapes the relative attractiveness of open MRI deployments and the types of clinical use cases prioritized by providers.

A strategic review of competitive forces showing how product engineering, component specialization, lifecycle services, and partnerships define leadership in open MRI systems

Competitive dynamics in the open MRI systems arena are defined by a mix of established imaging OEMs, specialized component suppliers, and agile integrators that bridge hardware and software capabilities. Manufacturers that combine robust engineering for magnets and gradients with advanced RF management and reconstruction algorithms tend to command strong clinical credibility. At the same time, component vendors that supply gradient coil innovations, high-efficiency power supply units, and next-generation RF chains play a pivotal role in enabling platform differentiation.

Service and lifecycle management capabilities increasingly shape competitive positioning. Companies that provide predictable maintenance contracts, modular upgrade paths, and local service networks can reduce procurement friction for large health systems and outpatient chains. Moreover, firms that offer comprehensive training programs and streamlined adoption support for technologists and radiologists often achieve higher utilization and stronger client retention. Partnerships between component specialists and systems integrators can accelerate innovation cycles, while vertically integrated players that control magnet manufacturing and system assembly may capture efficiencies in lead times and serviceability.

Strategic collaborations with software vendors and clinical partners are another distinguishing feature among leading organizations. Those that invest in validated imaging protocols, evidence generation, and clinical training create a stronger value proposition for adoption across specialized applications such as neurological and musculoskeletal imaging. Ultimately, the competitive landscape rewards companies that balance engineering excellence with dependable post-sale support and adaptive commercialization models.

Actionable recommendations that guide product modularity, integrated software development, resilient supply chains, enhanced service models, and outcome-aligned commercial strategies

Industry leaders should prioritize a set of actionable measures that align product development, commercial strategy, and operational resilience to the evolving clinical and regulatory environment. First, invest in modular platform architectures that permit incremental upgrades to gradient assemblies, RF subsystems, and power electronics, thereby extending useful life and reducing the need for full-system replacement. This approach enables providers to plan phased capital investments while maintaining technological relevance.

Second, accelerate collaboration between hardware teams and software developers to optimize image reconstruction, artifact mitigation, and workflow automation. Integrated solutions that reduce exam times and simplify protocol standardization can materially improve throughput and staff productivity. In parallel, manufacturers should expand clinical validation programs that demonstrate equivalency or superiority in targeted applications such as musculoskeletal and breast imaging.

Third, develop resilient supply chain strategies that blend onshore stocking, multi-sourcing of critical components, and transparent cost pass-through mechanisms. Nearshoring of critical subassemblies where feasible can reduce exposure to tariff volatility and logistical disruption. Fourth, design service and training models that reduce the operational burden on clinical teams, including remote diagnostics, predictive maintenance analytics, and comprehensive onboarding curricula for technologists and radiologists.

Finally, deepen engagement with end-users through tailored financing options and outcome-aligned contracting that reflect the performance and utilization realities of open platforms. By aligning commercial structures with clinical and operational value, industry leaders can accelerate adoption while mitigating procurement friction and supporting sustained clinical integration.

A transparent research methodology combining stakeholder interviews, technical benchmarking, secondary document analysis, and scenario-based sensitivity assessments for robust insights

The research underpinning this analysis combines qualitative and quantitative techniques designed to produce a comprehensive and reproducible view of the open MRI systems landscape. Primary inputs include structured interviews with clinical leaders, biomedical engineers, procurement officers, and service managers across a representative set of healthcare delivery environments. These interviews were complemented by technical assessments of component architectures, publicly available regulatory filings, and peer-reviewed clinical literature focusing on imaging performance and patient outcomes.

Secondary inputs encompassed product technical specifications, published upgrade and maintenance protocols, and corporate disclosures on manufacturing footprints and service networks. Where appropriate, comparative technical benchmarking was applied to evaluate gradient coil performance, magnet homogeneity considerations, and radio frequency system efficiencies. Triangulation methods were used to reconcile insights from industry interviews with observed technical data, ensuring that conclusions rest on a robust evidentiary foundation.

Throughout the analysis, care was taken to assess the implications of trade and policy shifts through scenario-based sensitivity analyses rather than singular deterministic views. This methodological choice enables stakeholders to understand a range of plausible outcomes and to prioritize strategic responses that improve resilience. The research process emphasized transparency in assumptions, reproducibility of technical assessments, and validation against clinician feedback to ensure practical applicability.

A concise conclusion summarizing the strategic relevance of open MRI platforms, technological progress, supply chain imperatives, and practical adoption considerations

Open MRI systems occupy a growing and nuanced role within contemporary diagnostic imaging ecosystems by offering patient-centric alternatives that align with evolving care delivery models. Technological advances in gradient and RF design, coupled with improvements in reconstruction software, have narrowed performance differentials and expanded clinical applicability. At the same time, supply chain and policy pressures have highlighted the need for resilient sourcing strategies and adaptable service propositions that prioritize long-term operational continuity.

For clinical leaders, the decision to deploy open platforms requires a balanced assessment of application-specific performance, patient experience imperatives, and integration with broader imaging portfolios. For manufacturers and service providers, success depends on delivering modular, upgradeable platforms backed by comprehensive lifecycle support and validated clinical protocols. Looking ahead, the most successful stakeholders will be those who combine engineering innovation with pragmatic commercial terms and localized service footprints to meet the real-world demands of diverse healthcare settings.

In sum, open MRI systems are positioned not merely as a niche alternative but as a strategic complement to the imaging mix, especially where patient comfort, accessibility, and specific clinical indications align with the platform's strengths.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Open MRI Systems Market, by Component

  • 8.1. Gradient Coils
  • 8.2. Magnets
  • 8.3. Power Supply Units
  • 8.4. Radio Frequency System

9. Open MRI Systems Market, by Field Strength

  • 9.1. High Field Strength
  • 9.2. Low Field Strength
  • 9.3. Mid Field Strength

10. Open MRI Systems Market, by Imaging Mode

  • 10.1. 2D Imaging
  • 10.2. 3D Imaging

11. Open MRI Systems Market, by Application

  • 11.1. Breast Imaging
  • 11.2. Cardiovascular Imaging
  • 11.3. Neurological Imaging
  • 11.4. Spine & Musculoskeletal Imaging

12. Open MRI Systems Market, by End Users

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Diagnostic Centers
  • 12.3. Hospitals
  • 12.4. Research Organizations

13. Open MRI Systems Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Open MRI Systems Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Open MRI Systems Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Open MRI Systems Market

17. China Open MRI Systems Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Alliance Medical Systems
  • 18.6. ASG Superconductors spa
  • 18.7. Barco N.V.
  • 18.8. Beijing Wandong Medical Technology Co.
  • 18.9. Bruker Corporation
  • 18.10. Canon Medical Systems Corporation
  • 18.11. Esaote S.p.A
  • 18.12. Fonar Corporation
  • 18.13. FUJIFILM Holdings Corporation
  • 18.14. GE HealthCare Technologies, Inc.
  • 18.15. Hitachi Healthcare Manufacturing, Ltd.
  • 18.16. Hologic, Inc.
  • 18.17. Koninklijke Philips N.V.
  • 18.18. Paramed Medical Systems, Inc.
  • 18.19. Siemens AG
  • 18.20. SternMed GmbH
  • 18.21. VISION STAR PRIVATE LIMITED

LIST OF FIGURES

  • FIGURE 1. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL OPEN MRI SYSTEMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL OPEN MRI SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES OPEN MRI SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA OPEN MRI SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY GRADIENT COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY GRADIENT COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY GRADIENT COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY MAGNETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY MAGNETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY MAGNETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY POWER SUPPLY UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY POWER SUPPLY UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY POWER SUPPLY UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY RADIO FREQUENCY SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY RADIO FREQUENCY SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY RADIO FREQUENCY SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY HIGH FIELD STRENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY HIGH FIELD STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY HIGH FIELD STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY LOW FIELD STRENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY LOW FIELD STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY LOW FIELD STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY MID FIELD STRENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY MID FIELD STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY MID FIELD STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY 2D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY 3D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY BREAST IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY BREAST IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY BREAST IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY NEUROLOGICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY NEUROLOGICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY NEUROLOGICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY SPINE & MUSCULOSKELETAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY SPINE & MUSCULOSKELETAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY SPINE & MUSCULOSKELETAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS OPEN MRI SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 114. GCC OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GCC OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 116. GCC OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 117. GCC OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 118. GCC OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. GCC OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 132. G7 OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. G7 OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 134. G7 OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 135. G7 OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 136. G7 OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. G7 OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 138. NATO OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. NATO OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 140. NATO OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 141. NATO OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 142. NATO OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. NATO OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL OPEN MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES OPEN MRI SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA OPEN MRI SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA OPEN MRI SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA OPEN MRI SYSTEMS MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 154. CHINA OPEN MRI SYSTEMS MARKET SIZE, BY IMAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA OPEN MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA OPEN MRI SYSTEMS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)